The FDA's Oncologic Drugs Advisory Committee has casted their votes on the utilization of certain treatments in the multiple ...

FDA grants priority review to TAR-200, which demonstrated an 82% complete response in high-risk bladder cancer unresponsive ...

An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.

Cancer leaves deep emotional scars long after treatment ends, but for many survivors, honest, unfiltered writing can be a ...

When asked to choose a word other than “survivor” to describe myself, I chose “person” because cancer does not define who I ...

After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked ...

The FDA granted breakthrough therapy designation to first-line treatment with Enhertu plus Perjeta for unresectable or metastatic HER2+ breast cancer.

Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for ...

SH-110, a liquid cancer treatment for glioma, earned orphan drug status from the FDA, helping patients who struggle to ...

Terry Gillespie said the hardest parts of her cancer journey were the isolation, the impact of chemotherapy, and how ...

Carotuximab plus Erleada proved safe in the first 10 patients with metastatic castration-resistant prostate cancer dosed on ...

Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...